研究人员开发血液测试 能够以86%的精度 检测早期帕金森氏病 Researchers develop blood test that may detect early-stage Parkinson's with 86% accuracy.

以色列研究人员进行了血液测试,通过测量与病情相关的具体RNA碎片,可以帮助检测早期帕金森氏病。 Israeli researchers have developed a blood test that may help detect early-stage Parkinson's disease by measuring specific RNA fragments linked to the condition. 测试发表在《自然老龄化》上,评估了两种生物标志,精确度达到86%,有可能在出现症状之前进行早期干预和治疗。 The test, published in Nature Aging, assesses two biomarkers with 86% accuracy, potentially allowing for early intervention and treatment before symptoms appear. 这可能为早期诊断和治疗帕金森氏病带来新的希望,影响全球数百万人。 This could offer new hope for early diagnosis and treatment of Parkinson's, affecting millions globally.